73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers

Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers

byKumamoto UniversityCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-1890Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immu

Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers

byKumamoto UniversityCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-1890Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immu
Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

by Instituto de Medicina MolecularGraphical abstract. Credit:Neuro-Oncology Advances(2023). DOI: 10.1093/noajnl/vdad048A new study led by Cláudia C. Faria, researcher in the lab of João Ta

Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

by Instituto de Medicina MolecularGraphical abstract. Credit:Neuro-Oncology Advances(2023). DOI: 10.1093/noajnl/vdad048A new study led by Cláudia C. Faria, researcher in the lab of João Ta
Zika virus could help combat brain cancer

Zika virus could help combat brain cancer

by FAPESPStudy by Brazilian researchers shows infection by Zika caused death of cells from glioblastoma, the most common and aggressive kind of malignant brain tumor in adults . Credit: cytopathi

Zika virus could help combat brain cancer

by FAPESPStudy by Brazilian researchers shows infection by Zika caused death of cells from glioblastoma, the most common and aggressive kind of malignant brain tumor in adults . Credit: cytopathi
Sperm quality unaffected by one course of chemotherapy for early testicular cancer

Sperm quality unaffected by one course of chemotherapy for early testicular cancer

by European Society for Medical OncologyHuman sperm stained for semen quality testing in the clinical laboratory. Credit: Bobjgalindo/WikipediaMen with early stage testicular cancer can safely re

Sperm quality unaffected by one course of chemotherapy for early testicular cancer

by European Society for Medical OncologyHuman sperm stained for semen quality testing in the clinical laboratory. Credit: Bobjgalindo/WikipediaMen with early stage testicular cancer can safely re
Major breakthrough in quest for cancer vaccine

Major breakthrough in quest for cancer vaccine

by University of MontrealCredit: CC0 Public DomainThe idea of a cancer vaccine is something researchers have been working on for over 50 years, but until recently they were never able to prove ex

Major breakthrough in quest for cancer vaccine

by University of MontrealCredit: CC0 Public DomainThe idea of a cancer vaccine is something researchers have been working on for over 50 years, but until recently they were never able to prove ex
Colorectal cancer: New approach for better efficacy of immunotherapies

Colorectal cancer: New approach for better efficacy of immunotherapies

byMedical University of ViennaSingle-cell RNA- and TCR sequencing reveal favored Vδ1+ usage with expanded CDR3 identity patterns in γδ T cells of MSS CRC. Credit:Nature Communications&nbsp

Colorectal cancer: New approach for better efficacy of immunotherapies

byMedical University of ViennaSingle-cell RNA- and TCR sequencing reveal favored Vδ1+ usage with expanded CDR3 identity patterns in γδ T cells of MSS CRC. Credit:Nature Communications&nbsp
Advanced ovarian cancer drug gets initial 'no' for NHS in England

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r
Researcher and her students discover lesser-known gene associated with breast cancer

Researcher and her students discover lesser-known gene associated with breast cancer

by Villanova UniversityCredit: Villanova UniversityVillanova University biology professor Janice Knepper, PhD, and her students have discovered that a gene, previously poorly characterized, can b

Researcher and her students discover lesser-known gene associated with breast cancer

by Villanova UniversityCredit: Villanova UniversityVillanova University biology professor Janice Knepper, PhD, and her students have discovered that a gene, previously poorly characterized, can b
Research offers new approach to nongenetic T-cell-based immunotherapy

Research offers new approach to nongenetic T-cell-based immunotherapy

by WileyCredit: WileyImmunotherapies for cancer aim to induce the immune system to combat cancer cells more effectively. In the journalAngewandte Chemie International Edition, a Chinese res

Research offers new approach to nongenetic T-cell-based immunotherapy

by WileyCredit: WileyImmunotherapies for cancer aim to induce the immune system to combat cancer cells more effectively. In the journalAngewandte Chemie International Edition, a Chinese res
Taming overactive molecular signaling in renal cell cancer

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat
First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer

First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris

First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris
Immune targets for chemotherapy-resistant breast cancers identified

Immune targets for chemotherapy-resistant breast cancers identified

byKing's College LondonAnalysis of stromal TILs in residual disease and prognostic implications. A) Kaplan–Meier curves for i) progression free survival and ii) overall survival in ER+HER2-

Immune targets for chemotherapy-resistant breast cancers identified

byKing's College LondonAnalysis of stromal TILs in residual disease and prognostic implications. A) Kaplan–Meier curves for i) progression free survival and ii) overall survival in ER+HER2-